Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology
Press Releases
Immunic, Inc.  
November 13, 2024

Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology

– Includes Phase 1 Data in Healthy Human Subjects and Phase 1b Data in Celiac Disease Patients –

avatar profile Olean Times Herald

Olean Times Herald


Local & Social